Navigation Links
Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C
Date:3/9/2009

erence call will be available within a few hours after the call ends. Investors may listen to the replay by dialing (888) 203-1112 or (719) 457-0820 confirmation code 4076361. Today's conference call also will be webcast and can be accessed at www.hgsi.com. Investors interested in listening to the live webcast should log on before the conference call begins to download any software required. Both the audio replay and the archive of the conference call webcast will remain available for several days.

About Human Genome Sciences

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs. The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax and cancer.

The Company's primary focus is rapid progress toward the commercialization of its two lead drugs, Albuferon(R) (albinterferon alfa-2b) for hepatitis C and LymphoStat-B(R) (belimumab) for lupus. Albuferon has now completed Phase 3 development, and the filing of global marketing applications is expected in fall 2009. Two Phase 3 clinical trials of LymphoStat-B are ongoing, with results expected in July and November 2009.

In January 2009, HGS began delivery of 20,000 doses of ABthrax(TM) (raxibacumab) to the U.S. Strategic National Stockpile for use in the event of an emergency for the treatment of inhalation anthrax. The Company also has several drugs in earlier stages of clinical development for the treatment of cancer, led by the TRAIL receptor antibody HGS-ETR1 and a small-molecule antagonist of IAP (inhibitor of apoptosis) proteins. In addition, HGS has substantial financial rights to certain products in the GSK clinical pipeline including darapladib, currently in Phase 3 development as a potential treatment for coronary heart disease, and Syncria(R) (albiglutide), curren
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Drug Development Program Started Based on CAP(R) Human Cell Line
2. Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments
3. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile
4. GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
5. FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
6. Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs
7. Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile
8. Mardil Inc. Advances Its Novel Cardiac Device to First-In-Human Trials for Mitral Valve Regurgitation
9. Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
10. Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
11. Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 2015  Check-Cap Ltd. (NASDAQ: CHEK ), a ... of a preparation-free ingestible imaging capsule that utilizes low-dose ... its CEO, Guy Neev , will ring the ... Neev and Check-Cap will participate in the closing bell ... offering and simultaneous private placement which raised a total ...
(Date:3/30/2015)... 30, 2015  Building on the momentum of the first ... of medical alert systems, has announced aggressive plans to expand ... and Managed Care business models. The first quarter ... Tennessee and Louisiana ... contracts to span statewide coverage in each state. This brings ...
(Date:3/30/2015)... 2015 Research and Markets ... of the "Urological Catheters - Global ... offering. This report analyzes the ... Units and US$ Thousands by the following ... Peritoneal Catheters), and Urinary Catheters (Foley Catheters, ...
Breaking Medicine Technology:Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 2Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 3MedScope's Aggressive 2015 Expansion Focuses on Medicaid Waiver and Managed Care Organizations 2Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 2Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 3Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 4Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 5Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 6Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 7
... N.J., Oct. 20 A meta-analysis of clinical data ... for the European Association for the Study of Diabetes ... (insulin detemir [rDNA origin] injection) was not associated with ... to human insulin(1,2). , The analysis conducted by ...
... Oct. 20 Digirad Corporation (Nasdaq: DRAD ) announced ... make an investor presentation at the BIOCOM 4th Annual Investor ... conference will be held at the Hyatt Regency La Jolla ... with slides will include a discussion of Digirad,s business, strategic ...
Cached Medicine Technology:Data Analysis Reinforces the Safety Profile of Levemir(R) 2Data Analysis Reinforces the Safety Profile of Levemir(R) 3Data Analysis Reinforces the Safety Profile of Levemir(R) 4
(Date:3/31/2015)... If you or someone you love is ... Irritable Bowel Syndrome (IBS), you will want to tune ... Television® at 7:30am EDT/PDT on either Wednesday, April 1st ... informative health segment featuring interviews with Board Certified Gastroenterologist ... and Medical Scientist Victoria Jaison, PhD. To learn more, ...
(Date:3/31/2015)... “ Prong ” was featured on NewsWatch as part ... coolest technology products available to consumers. Scott Steinberg, a technology ... shared with viewers how this phone case ensures that users ... when their phone is running out of power and they ... that is a solution to this problem. The PWR Case ...
(Date:3/31/2015)... 2015 A new study by Health eCareers ... rank employee turnover as their greatest staffing concern this year ... the battle – once you have them, you need to ... trends in healthcare recruiting blog series , which profiles ... Turnover in hospitals has high numbers and results in high ...
(Date:3/31/2015)... The Buffalo Bills athletic training staff ... for distinguished service to its club, community, and the ... Trainers’ Association (NYSATA) is proud to recognize such a ... - especially during March as part of National Athletic ... for NFL Athletic Training Staff of the Year ...
(Date:3/30/2015)... Fl (PRWEB) March 31, 2015 AlignLife ... Hamtaee has recently opened his AlignLife clinic. As part ... offering of chiropractic, rehabilitation and nutritional consulting for all ... AlignLife is based on the expertise and compassion of ... pass a rigorous evaluation process and an extensive training ...
Breaking Medicine News(10 mins):Health News:EnteraGam® to Be Featured on The Balancing Act® Airing on Lifetime Television® 2Health News:EnteraGam® to Be Featured on The Balancing Act® Airing on Lifetime Television® 3Health News:EnteraGam® to Be Featured on The Balancing Act® Airing on Lifetime Television® 4Health News:The Swiss Army Knife of Phone Cases was Featured on NewsWatch Television 2Health News:New Survey Finds Staff Turnover Top Concern for Healthcare Recruiters in 2015 2Health News:New Survey Finds Staff Turnover Top Concern for Healthcare Recruiters in 2015 3Health News:New Survey Finds Staff Turnover Top Concern for Healthcare Recruiters in 2015 4Health News:NYS Athletic Trainers' Association Congratulates Buffalo Bills Athletic Training Staff for National Award 2Health News:NYS Athletic Trainers' Association Congratulates Buffalo Bills Athletic Training Staff for National Award 3
... a Cesarean operation to deliver Japan's male heir. The ... doctor of the Imperial Household agency//. ,he ... the placenta, a condition called as placenta previa. "We ... operation. It is also highly possible that the delivery ...
... places and has put the draft regulation out for consultation//. ... government wanted to know about the people's views ahead of ... that it would be nice if the smoking ban extended ... that the plan would be expensive and is very complicated. ...
... chemicals and pharmaceutical companies have evinced interest to ... Chemicals Co already committing Rs 1,665 crore investment ... , Union Chemicals and Fertilisers Minister Ram Vilas ... led a delegation to Japan recently, said during ...
... human cancers involve mutations in the p53 tumor-suppressor gene, ... protein in defending// against cancer. Similarly, roughly 95 percent ... its DNA-binding core domain, pointing to this region of ... activity. ,Clearly, a detailed view of the ...
... dangers of sun exposure that are backed by research proving ... of developing skin// cancer, Americans are still getting sunburned. ... American Academy of Dermatology reported that 39 percent of respondents ... one sunburn in the previous 12 months, a 22 percent ...
... researchers, in collaboration with investigators at Johns Hopkins University, ... new vaccine against the West Nile virus. ... making its yearly appearance in Middle Tennessee. While no ... the state so far this season, mosquitoes collected from ...
Cached Medicine News:Health News:DNA-bound p53 Tumor Suppressor Protein Structure Determined 2Health News:Age and Socioeconomic Factors Are Strongest Determinants of Sunburn 2Health News:Age and Socioeconomic Factors Are Strongest Determinants of Sunburn 3Health News:University Participating in West Nile Vaccine Trial 2
This set is designed to introduce the low vision practitioner to the Keeler telescopic system....
... Featuring up to 20 ... examination in the vertical, ... plus the option to ... corneal transillumination., ,Filters include ...
Comes complete in its own carrying case. There are 24 lenses, 13mm diameter -6D to +6D in 0.5D steps. Mounted in tough, yet light alloy frame....
... Interventions, like all important missions, ... guide you to your destination. ... you this dependability. So you ... the intervention and not have ...
Medicine Products: